Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx information for visually impaired

Executive Summary

FDA is seeking comments on the accessibility of pharmaceutical information to the visually impaired for a study mandated by the Medicare Modernization Act. In a May 20 Federal Register notice, the agency asks "how do people who are blind and visually impaired currently get their drug information"; "what assistive technologies are currently used"; and "how can essential drug information be effectively communicated to people who are blind and visually impaired." Comments are due by June 21...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS044042

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel